EU recommends Parkinson’s drug for approval
Wednesday, December 24, 2014 - 06:20
in Health & Medicine
First new molecule for a decade, but Alzheimer’s still posing challenges as antibody treatment withdrawn from trials
First new molecule for a decade, but Alzheimer’s still posing challenges as antibody treatment withdrawn from trials